Studer L, Tabar V, McKay R D
Laboratory of Molecular Biology, NINDS, NIH, Bethesda, Maryland 20892, USA.
Nat Neurosci. 1998 Aug;1(4):290-5. doi: 10.1038/1105.
In vitro expansion of central nervous system (CNS) precursors might overcome the limited availability of dopaminergic neurons in transplantation for Parkinson's disease, but generating dopaminergic neurons from in vitro dividing precursors has proven difficult. Here a three-dimensional cell differentiation system was used to convert precursor cells derived from E12 rat ventral mesencephalon into dopaminergic neurons. We demonstrate that CNS precursor cell populations expanded in vitro can efficiently differentiate into dopaminergic neurons, survive intrastriatal transplantation and induce functional recovery in hemiparkinsonian rats. The numerical expansion of primary CNS precursor cells is a new approach that could improve both the ethical and the technical outlook for the use of human fetal tissue in clinical transplantation.
中枢神经系统(CNS)前体细胞的体外扩增或许能克服帕金森病移植中多巴胺能神经元来源有限的问题,但从体外分裂的前体细胞生成多巴胺能神经元已被证明颇具难度。在此,我们采用一种三维细胞分化系统,将源自E12大鼠腹侧中脑的前体细胞转化为多巴胺能神经元。我们证明,体外扩增的中枢神经系统前体细胞群体能够高效分化为多巴胺能神经元,在纹状体内移植后存活,并能诱导偏侧帕金森病大鼠的功能恢复。原代中枢神经系统前体细胞的数量扩增是一种新方法,有望改善临床移植中使用人类胎儿组织的伦理和技术前景。